Post-acute metabolic changes and risk of new-onset diabetes following COVID-19: a systematic review and meta-analysis - Top-Institutions - MDSpire

Post-acute metabolic changes and risk of new-onset diabetes following COVID-19: a systematic review and meta-analysis

  • By

  • Bukola Lawal

  • Shuaibu Saidu Musa

  • May Soe Thu

  • Thunnicha Ondee

  • Oranut Chatsirisakul

  • Krit Pongpirul

  • May 21, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Diabetes

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Endocrinology
    • Diabetes

  • #3

    Johns Hopkins Health System
    Johns Hopkins Health System

    Baltimore, Maryland

    Key Differentiators

    • Endocrinology

  • #4

    Children's Medical Center Dallas
    Children's Medical Center Dallas

    Dallas, Texas

    Key Differentiators

    • Pediatric Endocrinology

  • #5

    COVIP-trial
    COVIP-trial

    N/A, N/A

    Key Differentiators

    • Clinical Research

Original Source(s)

Post-acute metabolic changes and risk of new-onset diabetes following COVID-19: a systematic review and meta-analysis

  • by Bukola Lawal, Shuaibu Saidu Musa, May Soe Thu, Thunnicha Ondee, Oranut Chatsirisakul, Krit Pongpirul

  • May 21, 2026

Related Content

Hybrid Care Modifications in the Delivery of Nonpandemic Care During the COVID-19 Pandemic: Scoping Review

Suprachoroidal Injection in the Treatment of Diabetic Macular Edema: Mechanisms, Clinical Advances, and Future Perspectives

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

  • May 27, 2026

  • 3 min